BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 734164)

  • 1. Urinary carcinoembryonic like antigen levels in patients with urinary tract reconstruction using bowels.
    Oshiumi Y; Yagi H; Nishitani H; Nakayama C; Kamoi I; Matsuura K; Momose S
    Radioisotopes; 1978 Aug; 27(8):456-9. PubMed ID: 734164
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Increased serum carcinoembryonic antigen level in patients undergoing colon neobladder replacement compared with ileal neobladder replacement.
    Hara I; Miyake H; Hara S; Takechi Y; Eto H; Fujisawa M; Okada H; Arakawa S; Kamidono S
    Urology; 2002 Aug; 60(2):363-7. PubMed ID: 12137854
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Urinary carcinoembryonic antigen (CEA)-like molecules and urothelial malignancy: a clinical appraisal.
    Coombers GB; Hall RR; Laurence JR; Neville AM
    Br J Cancer; 1975 Feb; 31(2):135-42. PubMed ID: 1164465
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Urinary carcinoembryogenic antigen (CEA) in the diagnosis and follow-up of bladder carcinoma.
    Tailly G; Cornelissen M; Vereecken RL; Verduyn H; Devos P; De Roo M
    Br J Urol; 1983 Oct; 55(5):501-7. PubMed ID: 6626896
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Diagnostic value of urine cytology and urine carcinoembryonic antigen (CEA) level in the distinction between bladder cancer and urinary tract infection.
    Gajda M; Tyloch F; Jóźwicki W; Tyloch J; Sujkowska R; Skok Z
    Int J Occup Med Environ Health; 1995; 8(2):103-8. PubMed ID: 7582848
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Elevated CEA values after cystectomy for bladder cancer and intestinal urinary diversion not evidence of tumor recurrence].
    Klippel KF; Axt D; Schärfe T; Preiss J; Alves de Oliveira CR
    Onkologie; 1983 Jun; 6(3):126, 127-31. PubMed ID: 6350964
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Urine carcinoembryonic antigen determination in urinary bladder bilharziasis predicts carcinoma in patients with premalignant lesions: observation of 43 cases in Egypt.
    Saied GM; El-Metenawy WH; Elwan MS; Dessouki NR
    Tanzan Health Res Bull; 2006 Sep; 8(3):122-7. PubMed ID: 18254501
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Carcinoembryonic antigen in urine in patients with urothelial carcinoma. An expression for the extent of inflammatory reaction of the urinary tract.
    Colleen S; Ek A; Gullberg B; Johansson BG; Lindberg LG; Olsson AM
    Scand J Urol Nephrol; 1979; 13(2):149-53. PubMed ID: 482866
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Assessment of serial CEA determinations in urine of patients with bladder carcinoma.
    Zimmerman R; Wahren B; Edsmyr F
    Cancer; 1980 Oct; 46(8):1802-9. PubMed ID: 7427883
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Tumor markers (CEA, TPA and CA 19-9) in urine of bladder cancer patients.
    Tizzani A; Cassetta G; Cicigoi A; Piana P; Cerchier A; Pecchio F; Piantino P
    Int J Biol Markers; 1987; 2(2):121-4. PubMed ID: 3482861
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Clinical significance of urinary CEA measurement as a screening test of bladder cancer (author's transl)].
    Oshiumi Y; Yagi H; Nishitani H; Yamawaki H; Nakayama C; Kamoi I; Matsuura K; Momose S
    Radioisotopes; 1979 Jun; 28(6):367-70. PubMed ID: 531259
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Urine carcinoembryonic antigen levels are more useful than serum levels for early detection of Bilharzial and non-Bilharzial urinary bladder carcinoma: observations of 43 Egyptian cases.
    Saied GM; El-Metenawy WH; Elwan MS; Dessouki NR
    World J Surg Oncol; 2007 Jan; 5():4. PubMed ID: 17224047
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clinical evaluation of urinary and serum carcinoembryonic antigen in bladder cancer.
    Fraser RA; Ravry MJ; Segura JW; Go VL
    J Urol; 1975 Aug; 114(2):226-9. PubMed ID: 1159914
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Measurement of urinary CEA-like substance. An aid in management of patients with bladder carcinoma.
    Wahren B; Edsmyr F; Zimmerman R
    Cancer; 1975 Oct; 36(4):1490-5. PubMed ID: 1175143
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Blood and urinary values of CEA and CA 19-9 in patients with bladder carcinoma].
    Cicigoi A; Rocca Rossetti S; Piantino P; Cerchier A
    Minerva Med; 1986 Nov; 77(42-43):1983-7. PubMed ID: 3464851
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effects of therapy on carcinoembryonic antigen activity in the urines of patients with cancer of the bladder.
    James K; Alroy J; Miller AW; Flanagan M
    Am J Clin Pathol; 1980 Feb; 73(2):250-3. PubMed ID: 6766663
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Evaluation of a double-monoclonal radioimmunoassay for the measurement of carcinoembryonic antigen in the urine of patients with bladder cancer.
    Hetherington JW; Ewing R; Cooper EH
    Eur Urol; 1986; 12(4):270-3. PubMed ID: 3743597
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Proceedings: Clinical evaluation of CEA in urine of patients with bladder carcinoma.
    Korsten CB; Persijn JP; Renaud J
    Br J Cancer; 1974 Aug; 30(2):174-5. PubMed ID: 4419334
    [No Abstract]   [Full Text] [Related]  

  • 19. Carcino-embryonic antigen activity in urine of patients with bladder carcinoma. Clinical evaluation of carcino-embryonic antigen. II.
    Korsten CB; Persijn JP; Renaud J; Houtzager-Boelens CA
    J Clin Chem Clin Biochem; 1976 Aug; 14(8):389-93. PubMed ID: 965892
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Urinary CEA for prediction of survival time and recurrence in bladder cancer.
    Wahren B; Nilsson B; Zimmerman R
    Cancer; 1982 Jul; 50(1):139-45. PubMed ID: 7083117
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.